Halaman 3 - Adenokarsinoma sigmoid Dokter Terbaik - TOP-92 dokter

Dosen Lektor Kepala sejak 2016, Dr. Ozatli membawa ketelitian akademis dalam mengobati kanker gastrointestinal di Istinye University Liv Hospital Bahcesehir.

• Berupaya spesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal
• Menjadi spesialis penyakit dalam dengan pengalaman di berbagai rumah sakit
• Mempraktikkan onkologi di Klinik Onkologi Ankara dan Rumah Sakit Pelatihan Regional Erzurum
• Menempuh pendidikan di Fakultas Kedokteran Universitas Selcuk

Dr. Viola Fox memimpin pusat kanker interdisipliner bersertifikat BKZ Solingen, yang berspesialisasi dalam perawatan lanjutan untuk adenokarsinoma sigmoid.

• Pengalaman lebih dari 15 tahun di bidang hematologi, onkologi, dan imunologi
• Ahli dalam kemoterapi, imunoterapi, dan terapi bertarget
• Spesialis berkualifikasi dalam genetika dan diagnostik molekuler
• Peneliti aktif dalam biologi molekuler untuk perawatan kanker
• Anggota masyarakat onkologi Jerman dan Amerika

Profesor Keil berspesialisasi dalam radiologi diagnostik dan intervensi, dengan pengalaman luas dalam pencitraan MRI dan CT untuk intervensi medis yang kompleks.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Berlatih di bawah bimbingan Profesor ternama Rolf W. Günther di Rumah Sakit Universitas Aachen
• Kepala Dokter Radiologi Diagnostik dan Intervensi di Rumah Sakit Akademik Solingen
• Ahli dalam pencitraan cross-sectional dan diagnostik ultrasonografi

Dr. Mustafa Serkan Alemdar adalah seorang spesialis Onkologi Medis dengan latar belakang akademis yang kuat dan pengalaman rumah sakit yang luas.

• Menjalani pelatihan di Universitas Akdeniz – salah satu sekolah kedokteran terkemuka di Turki
• Spesialisasi dalam Kedokteran Penyakit Dalam dan Onkologi Medis
• Memiliki pengalaman bertahun-tahun di berbagai rumah sakit ternama
• Berfokus pada perawatan dan pengobatan kanker yang komprehensif

Dr. Alon Pikarsky telah mengajar dan melatih ahli bedah baru selama lebih dari 20 tahun di departemen unggulan Pusat Medis Hadassah.

• Dosen Senior Bedah sejak 2005
• Direktur Program Residensi sejak 2000 – membina ahli bedah masa depan
• Sertifikasi spesialis dalam Bedah Umum dengan sub-spesialisasi Bedah Kolorektal
• Sertifikasi Dewan Israel dalam Bedah Umum sejak 1998
• Anggota lama di berbagai asosiasi bedah profesional

Spesialis dalam bedah laparoskopi untuk adenokarsinoma sigmoid – menempuh pendidikan di program unggulan Universitas Istanbul.

• Lebih dari 20 tahun pengalaman bedah
• Pelatihan lanjutan dalam bedah bariatrik laparoskopi dan bedah kanker onkologi
• Melakukan prosedur invasif minimal untuk pemulihan yang lebih baik

Assoc. Prof. Nail Paksoy berspesialisasi dalam onkologi medis di Rumah Sakit Medipol Bahcelievler, dengan fokus pada kanker gastrointestinal.

• Sertifikasi Dewan ESMO dalam Onkologi Medis
• Berpartisipasi dalam uji klinis internasional untuk pengobatan kanker kolorektal
• Menerbitkan penelitian tentang rejimen FLOT untuk kanker lambung metastatik

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Lebih dari 30 tahun di bidang imunologi dengan fokus pada viroterapi – Dr. Jaunalksne memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins.

• Berspesialisasi dalam salah satu bidang imunologi terbaru
• Lulusan Institut Medis Riga
• Menjalani magang di Penyakit Dalam
• Menjabat sebagai kepala Pusat Imunologi Klinis

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Spesialis dalam bedah onkologi, khususnya kanker kolon, dengan fokus pada kasus-kasus kompleks di Rumah Sakit Büyük Anadolu.

• Ahli dalam bedah pankreas dan saluran empedu
• Melakukan bedah bariatrik dan metabolik tingkat lanjut
• Terampil dalam prosedur kanker payudara dan tiroid

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Spesialis bedah endoskopi – Hanok Kashtan menghadirkan keahlian terfokus pada perawatan invasif minimal di Assuta Medical Center.

• Ahli dalam teknik endoskopi tingkat lanjut untuk kondisi kolorektal
• Bekerja di Assuta – rumah sakit swasta terkemuka di Israel
• Melakukan pengangkatan tumor secara presisi dengan waktu pemulihan yang lebih cepat

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.